 | Up a level |
Diamond, Eli L., Subbiah, Vivek 
ORCID: 0000-0002-6064-6837, Lockhart, A. Craig, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Puzanov, Igor, Chau, Ian, Raje, Noopur S., Wolf, Jurgen, Erinjeri, Joseph P., Torrisi, Jean, Lacouture, Mario, Elez, Elena ORCID: 0000-0002-4653-6324, Martinez-Valle, Ferran, Durham, Benjamin ORCID: 0000-0001-8090-5448, Arcila, Maria E., Ulaner, Gary, Abdel-Wahab, Omar, Pitcher, Bethany, Makrutzki, Martina, Riehl, Todd, Baselga, Jose and Hyman, David M.
(2018).
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.
JAMA Oncol., 4 (3).
S. 384 - 389.
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 2374-2445